Cart
0

Self-Monitoring Blood Glucose Devices Market by Product (Test Strips, Lancets, and Blood Glucose Meters), Application (Type 1 Diabetes, Type 2 Diabetes, and Gestational Diabetes), and End User (Hospitals, Home Settings, and Diagnostic Centers) - Global Opportunity Analysis and Industry Forecast, 2018-2025

Get 20% Free Customization In This Report
LI_184149
Pages: 230
Sep 2018 | 1240 Views
 
Author's : Mayuri Srivastava & Pallavi Jaiswal
Tables: 116
Charts: 41
 

Self-Monitoring Blood Glucose Devices Market Overview:

The global self-monitoring blood glucose devices market was valued at $7,768 million in 2017 and is projected to reach $10,828 million by 2025 at a CAGR of 4.2% from 2018 to 2025. Monitoring of blood glucose is an essential step in diabetes management. Blood glucose monitoring devices are predominantly used to monitor a patient’s blood glucose level. Self-monitoring blood glucose (SMBG) devices are easy-to-use and enable people to monitor their blood glucose level irrespective of the location. SMBG devices include test strips, lancets, and blood glucose meters that monitor the blood glucose level.

Get more information on this report: Request Sample Pages

Market Dynamics

The growth of the global self-monitoring blood glucose devices market is majorly driven by increase in prevalence of diabetes, majorly type 2 diabetes. Other factors that boost the market growth include technological advancements in diabetes devices, rise in obese population, sedentary lifestyle, surge in need for faster and safer diagnosis & treatment of diabetes, and increase in geriatric population worldwide. Blood glucose monitoring devices present readings in a range rather than the exact number, which in turn could hamper the growth of the market. Conversely, high potential in untapped markets in the emerging economies are expected to provide lucrative growth opportunities for the market.

Market Segmentation

The global self-monitoring blood glucose devices market is segmented into product, application, end user, and region. Based on product, the market is divided into test strips, lancets, and blood glucose meters. The test strips segment accounted for the largest market share in 2017 and is expected to remain dominant throughout the forecast period owing to economical pricing of test strips as compared to glucose meters. In addition, easy availability of these strips is expected to boost the market growth. 

Get more information on this report: Request Sample Pages

Based on application, the market is categorized into type 1 diabetes, type 2 diabetes, and gestational diabetes. The type 2 diabetes segment accounted for the largest market share in 2017, owing to its high prevalence across the world. On the other hand, the gestational diabetes segment is expected to grow at a significant CAGR during the forecast period.

Get more information on this report: Request Sample Pages

Based on end user, the market is categorized into hospitals, home settings, and diagnostic centers. Based on region, the market is studied across North America, Europe, Asia-Pacific, and LAMEA. In 2017, Europe held the largest share of the market, followed by North America. On the other hand, Asia-Pacific is anticipated to dominate the market during the analysis period, owing to high population base, increase in disposable income, and improvement in patient awareness about self-monitoring blood glucose devices. 

Get more information on this report: Request Sample Pages

The key players profiled in the report include Abbott Laboratories, Becton, Dickinson and Company, B. Braun Melsungen AG, F. Hoffmann-La Roche Ltd., Johnson & Johnson, Medtronic plc, PHC Holdings Corporation, Sanofi, Terumo Corporation, and Trividia Health, Inc.

The other players in the value chain include ARKRAY USA, Nova Biomedical, Bionime Corporation, Sinocare, Inc., and All Medicus Co., Ltd. These players have not been profiled in the report but can be included on request.

Key Benefits for Stakeholders

  • The study provides an in-depth analysis of the global self-monitoring blood glucose devices market with current trends and future estimations from 2018 to 2025 to elucidate the imminent investment pockets.
  • Comprehensive analysis of the factors that drive and restrict the growth of the market is provided.
  • Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on the global & regional scale are provided.
  • Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the market.

Self-Monitoring Blood Glucose Devices Market Key Segments:

By Product

  • Test Strips
  • Lancets
  • Blood Glucose Meters

By Application

  • Type 1 Diabetes
  • Type 2 Diabetes
  • Gestational Diabetes

By End User

  • Hospitals
  • Home Settings
  • Diagnostic Centers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

Chapter: 1: INTRODUCTION

1.1. Report Description
1.2. Key Benefits for Stakeholders
1.3. Key Market Segments

1.3.1. List of key players profiled in the report

1.4. Research Methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2: EXECUTIVE SUMMARY

2.1. Key Findings of the Study
2.2. CXO perspective

Chapter: 3: MARKET OVERVIEW

3.1. Market Definition and Scope
3.2. Key Findings

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. Market Share Analysis, 2017 (%)
3.4. Market Dynamics

3.4.1. Drivers

3.4.1.1. Increase in the incidence rate of diabetes
3.4.1.2. Rise in geriatric population
3.4.1.3. Technological advancements in diabetes monitoring devices
3.4.1.4. Rise in risk factors that lead to diabetes

3.4.2. Restraints

3.4.2.1. Inaccurate results

3.4.3. Opportunity

3.4.3.1. Increase in awareness for diabetes monitoring devices
3.4.3.2. Untapped market opportunities in the developing regions

3.4.4. Impact analyses

Chapter: 4: SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT

4.1. Overview

4.1.1. Market size and forecast, by product

4.2. Test Strips

4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country

4.3. Lancets

4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country

4.4. Blood Glucose Meters

4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country

Chapter: 5: SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION

5.1. Overview

5.1.1. Market size and forecast, by revenue

5.2. Type 1 Diabetes

5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country

5.3. Type 2 diabetes

5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country

5.4. Gestational Diabetes

5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country

Chapter: 6: SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER

6.1. Overview

6.1.1. Market size and forecast

6.2. Hospitals

6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country

6.3. Home Settings

6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country

6.4. Diagnostic Centers

6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by country

Chapter: 7: SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY REGION

7.1. Overview

7.1.1. Market size and forecast

7.2. North America

7.2.1. Key market trends, growth factors, and opportunities
7.2.2. North America market size and forecast, by country

7.2.2.1. U.S.

7.2.2.1.1. U.S. market size and forecast, by product
7.2.2.1.2. U.S. market size and forecast, by application
7.2.2.1.3. U.S. market size and forecast, by end user

7.2.2.2. Canada

7.2.2.2.1. Canada market size and forecast, by product
7.2.2.2.2. Canada market size and forecast, by application
7.2.2.2.3. Canada market size and forecast, by end user

7.2.2.3. Mexico

7.2.2.3.1. Mexico market size and forecast, by product
7.2.2.3.2. Mexico market size and forecast, by application
7.2.2.3.3. Mexico market size and forecast, by end user

7.2.3. North America market size and forecast, by product
7.2.4. North America market size and forecast, by application
7.2.5. North America market size and forecast, by end user

7.3. Europe

7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Europe self-monitoring blood glucose devices market, by country

7.3.2.1. Germany

7.3.2.1.1. Germany market size and forecast, by product
7.3.2.1.2. Germany market size and forecast, by application
7.3.2.1.3. Germany market size and forecast, by end user

7.3.2.2. France

7.3.2.2.1. France market size and forecast, by product
7.3.2.2.2. France market size and forecast, by application
7.3.2.2.3. France market size and forecast, by end user

7.3.2.3. UK

7.3.2.3.1. UK market size and forecast, by product
7.3.2.3.2. UK market size and forecast, by application
7.3.2.3.3. UK market size and forecast, by end user

7.3.2.4. Italy

7.3.2.4.1. Italy market size and forecast, by product
7.3.2.4.2. Italy market size and forecast, by application
7.3.2.4.3. Italy market size and forecast, by end user

7.3.2.5. Spain

7.3.2.5.1. Spain market size and forecast, by product
7.3.2.5.2. Spain market size and forecast, by application
7.3.2.5.3. Spain market size and forecast, by end user

7.3.2.6. Rest of Europe

7.3.2.6.1. Rest of Europe market size and forecast, by product
7.3.2.6.2. Rest of Europe market size and forecast, by application
7.3.2.6.3. Rest of Europe market size and forecast, by end user

7.3.3. Europe market size and forecast, by product
7.3.4. Europe market size and forecast, by application
7.3.5. Europe market size and forecast, by end user

7.4. Asia-Pacific

7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Asia-Pacific market size and forecast, by country

7.4.2.1. Japan

7.4.2.1.1. Japan market size and forecast, by product
7.4.2.1.2. Japan market size and forecast, by application
7.4.2.1.3. Japan market size and forecast, by end user

7.4.2.2. China

7.4.2.2.1. China market size and forecast, by product
7.4.2.2.2. China market size and forecast, by application
7.4.2.2.3. China market size and forecast, by end user

7.4.2.3. India

7.4.2.3.1. India market size and forecast, by product
7.4.2.3.2. India market size and forecast, by application
7.4.2.3.3. India market size and forecast, by end user

7.4.2.4. Australia

7.4.2.4.1. Australia market size and forecast, by product
7.4.2.4.2. Australia market size and forecast, by application
7.4.2.4.3. Australia market size and forecast, by end user

7.4.2.5. South Korea

7.4.2.5.1. South Korea market size and forecast, by product
7.4.2.5.2. South Korea market size and forecast, by application
7.4.2.5.3. South Korea market size and forecast, by end user

7.4.2.6. Rest of Asia-Pacific

7.4.2.6.1. Rest of Asia-Pacific market size and forecast, by product
7.4.2.6.2. Rest of Asia-Pacific market size and forecast, by application
7.4.2.6.3. Rest of Asia-Pacific market size and forecast, by end user

7.4.3. Asia-Pacific market size and forecast, by product
7.4.4. Asia-Pacific market size and forecast, by application
7.4.5. Asia-Pacific market size and forecast, by end user

7.5. LAMEA

7.5.1. Key market trends, growth factors, and opportunities
7.5.2. LAMEA market size and forecast, by country

7.5.2.1. Brazil

7.5.2.1.1. Brazil market size and forecast, by product
7.5.2.1.2. Brazil market size and forecast, by application
7.5.2.1.3. Brazil market size and forecast, by end user

7.5.2.2. Saudi Arabia

7.5.2.2.1. Saudi Arabia market size and forecast, by product
7.5.2.2.2. Saudi Arabia market size and forecast, by application
7.5.2.2.3. Saudi Arabia market size and forecast, by end user

7.5.2.3. South Africa

7.5.2.3.1. South Arica market size and forecast, by product
7.5.2.3.2. South Arica market size and forecast, by application
7.5.2.3.3. South Arica market size and forecast, by end user

7.5.2.4. Rest of LAMEA

7.5.2.4.1. Rest of LAMEA market size and forecast, by product
7.5.2.4.2. Rest of LAMEA market size and forecast, by application
7.5.2.4.3. Rest of LAMEA market size and forecast, by end user

7.5.3. LAMEA market size and forecast, by product
7.5.4. LAMEA market size and forecast, by application
7.5.5. LAMEA market size and forecast, by end user

Chapter: 8: COMPANY PROFILES

8.1. Abbott Laboratories

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product Portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments

8.2. Becton, Dickinson and Company

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product Portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments

8.3. B. Braun Melsungen AG

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product Portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments

8.4. F. Hoffmann-La Roche Ltd.

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments

8.5. Johnson & Johnson

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product Portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments

8.6. Medtronic plc

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product Portfolio
8.6.5. Business performance
8.6.6. Key strategic moves and developments

8.7. PHC Holdings Corporation

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Key strategic moves and developments

8.8. Sanofi

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product Portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments

8.9. Terumo Corporation

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product Portfolio
8.9.5. Business performance

8.10. Trividia Health, Inc.

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio

LIST OF TABLES

TABLE 01. GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 02. SELF-MONITORING BLOOD GLUCOSE TEST STRIPS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 03. SELF-MONITORING BLOOD GLUCOSE LANCETS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 04. SELF-MONITORING BLOOD GLUCOSE METERS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 05. GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET REVENUE, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 06. SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR TYPE 1 DIABETES, BY REGION, 2017-2025 ($MILLION)
TABLE 07. SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR TYPE 2 DIABETES, BY REGION, 2017-2025 ($MILLION)
TABLE 08. SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR GESTATIONAL DIABETES, BY REGION, 2017-2025 ($MILLION)
TABLE 09. GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET REVENUE, BY END USER, 2017-2025 ($MILLION)
TABLE 10. SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR HOSPITALS, BY REGION, 2017-2025 ($MILLION)
TABLE 11. SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR HOME SETTINGS, BY REGION, 2017-2025 ($MILLION)
TABLE 12. SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2017-2025 ($MILLION)
TABLE 13. SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 14. NORTH AMERICA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 15. U.S. SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 16. U.S. SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 17. U.S. SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 18. CANADA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 19. CANADA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 20. CANADA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 21. MEXICO SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 22. MEXICO SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 23. MEXICO SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 24. NORTH AMERICA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 25. NORTH AMERICA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 26. NORTH AMERICA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 27. EUROPE SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 28. GERMANY SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 29. GERMANY SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 30. GERMANY SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 31. FRANCE SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 32. FRANCE SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 33. FRANCE SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 34. UK SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 35. UK SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 36. UK SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 37. ITALY SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 38. ITALY SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 39. ITALY SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 40. SPAIN SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 41. SPAIN SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 42. SPAIN SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 43. REST OF EUROPE SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 44. REST OF EUROPE SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 45. REST OF EUROPE SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 46. EUROPE SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 47. EUROPE SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 48. EUROPE SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 49. ASIA-PACIFIC SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 50. JAPAN SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 51. JAPAN SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 52. JAPAN SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 53. CHINA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 54. CHINA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 55. CHINA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 56. INDIA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 57. INDIA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 58. INDIA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 59. AUSTRALIA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 60. AUSTRALIA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 61. AUSTRALIA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 62. SOUTH KOREA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 63. SOUTH KOREA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 64. SOUTH KOREA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 65. REST OF ASIA-PACIFIC SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 66. REST OF ASIA-PACIFIC SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 67. REST OF ASIA-PACIFIC SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 68. ASIA-PACIFIC SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 69. ASIA-PACIFIC SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 70. ASIA-PACIFIC SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 71. LAMEA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 72. BRAZIL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 73. BRAZIL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 74. BRAZIL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 75. SAUDI ARABIA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 76. SAUDI ARABIA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 77. SAUDI ARABIA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 78. SOUTH ARICA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 79. SOUTH ARICA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 80. SOUTH ARICA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 81. REST OF LAMEA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 82. REST OF LAMEA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 83. REST OF LAMEA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 84. LAMEA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 85. LAMEA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 86. LAMEA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 87. ABBOTT: COMPANY SNAPSHOT
TABLE 88. ABBOTT: OPERATING SEGMENTS
TABLE 89. ABBOTT: PRODUCT PORTFOLIO
TABLE 90. BD: COMPANY SNAPSHOT
TABLE 91. BD: BUSINESS SEGMENTS
TABLE 92. BD: PRODUCT PORTFOLIO
TABLE 93. B. BRAUN: COMPANY SNAPSHOT
TABLE 94. B. BRAUN: OPERATING SEGMENTS
TABLE 95. B. BRAUN: PRODUCT PORTFOLIO
TABLE 96. ROCHE: COMPANY SNAPSHOT
TABLE 97. ROCHE: OPERATING SEGMENTS
TABLE 98. ROCHE: PRODUCT PORTFOLIO
TABLE 99. J&J: COMPANY SNAPSHOT
TABLE 100. J&J: OPERATING SEGMENTS
TABLE 101. J&J: PRODUCT PORTFOLIO
TABLE 102. MEDTRONIC: COMPANY SNAPSHOT
TABLE 103. MEDTRONIC: OPERATING SEGMENTS
TABLE 104. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 105. PHC HOLDINGS CORPORATION: COMPANY SNAPSHOT
TABLE 106. PHC HOLDINGS CORPORATION: BUSINESS SEGMENTS
TABLE 107. PHC HOLDINGS CORPORATION: PRODUCT PORTFOLIO
TABLE 108. SANOFI: COMPANY SNAPSHOT
TABLE 109. SANOFI: OPERATING SEGMENTS
TABLE 110. SANOFI: PRODUCT PORTFOLIO
TABLE 111. TERUMO: COMPANY SNAPSHOT
TABLE 112. TERUMO: OPERATING SEGMENTS
TABLE 113. TERUMO: PRODUCT PORTFOLIO
TABLE 114. TRIVIDIA HEALTH, INC.: COMPANY SNAPSHOT
TABLE 115. TRIVIDIA HEALTH, INC.: PRODUCT SEGMENTS
TABLE 116. TRIVIDIA HEALTH, INC.: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01. GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2015-2017*
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2015-2017* (%)
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2015-2017*
FIGURE 06. MARKET SHARE ANALYSIS, 2017
FIGURE 07. PERCENTAGE OF POPULATION AGED 65 AND OVER ACROSS THE WORLD: 2015 AND 2050
FIGURE 08. IMPACT ANALYSES
FIGURE 09. COMPARATIVE COUNTRY ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE TEST STRIPS MARKET FOR BRACKETS, 2017 & 2025 (%)
FIGURE 10. COMPARATIVE COUNTRY ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE LANCETS MARKET, 2017 & 2025 (%)
FIGURE 11. COMPARATIVE COUNTRY ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE METERS MARKET, 2017 & 2025 (%)
FIGURE 12. COMPARATIVE COUNTRY ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR TYPE 1 DIABETES, 2017 & 2025 (%)
FIGURE 13. COMPARATIVE COUNTRY ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR TYPE 2 DIABETES, 2017 & 2025 (%)
FIGURE 14. COMPARATIVE COUNTRY ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR GESTATIONAL DIABETES, 2017 & 2025 (%)
FIGURE 15. COMPARATIVE COUNTRY ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR HOSPITALS, 2017 & 2025 (%)
FIGURE 16. COMPARATIVE COUNTRY ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR HOME SETTINGS, 2017 & 2025 (%)
FIGURE 17. COMPARATIVE COUNTRY ANALYSIS OF SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET FOR DIAGNOSTIC CENTERS, 2017 & 2025 (%)
FIGURE 18. ABBOTT: NET SALES, 2015-2017 ($MILLION)
FIGURE 19. ABBOTT: NET SALES SHARE BY SEGMENT, 2017 (%)
FIGURE 20. ABBOTT: NET SALES SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 21. BD: NET SALES, 2015-2017 ($MILLION)
FIGURE 22. BD: REVENUE SHARE, BY SEGMENT, 2017 (%)
FIGURE 23. BD: REVENUE SHARE, BY GEOGRAPHY, 2017 (%)
FIGURE 24. NET SALES, 2015-2017 ($MILLION)
FIGURE 25. B. BRAUN: NET SALES BY SEGMENT, 2017 (%)
FIGURE 26. B. BRAUN: NET SALES BY GEOGRAPHY, 2017 (%)
FIGURE 27. ROCHE: NET SALES, 2015-2017 ($MILLION)
FIGURE 28. ROCHE: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 29. ROCHE: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 30. J&J: NET SALES, 2015-2017 ($MILLION)
FIGURE 31. J&J: REVENUE SHARE, BY SEGMENT, 2017 (%)
FIGURE 32. J&J: REVENUE SHARE, BY GEOGRAPHY, 2017 (%)
FIGURE 33. MEDTRONIC: NET SALES, 2015-2017 ($MILLION)
FIGURE 34. MEDTRONIC: NET SALES, BY SEGMENT, 2017 (%)
FIGURE 35. MEDTRONIC: NET SALES, BY GEOGRAPHY, 2017 (%)
FIGURE 36. SANOFI: NET SALES, 2015-2017 ($MILLION)
FIGURE 37. SANOFI: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 38. SANOFI: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 39. TERUMO: NET SALES, 2015-2017 ($MILLION)
FIGURE 40. TERUMO: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 41. TERUMO: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

 

Self-monitoring blood glucose devices are medical devices that help track blood glucose levels of diabetic patients. Self-monitoring is one of the essential diabetes management techniques, which involve measurement of blood glucose with the help of test strips and glucose meters. Self-management of blood glucose is performed by pricking the finger to draw blood, and then smearing it on the disposal test-strip. Self-monitoring blood glucose technique is recommended for people with diabetes to prevent the development of hypoglycemia and other diabetes-related problems. 

The adoption of diabetes care devices is expected to increase in the near future, owing to the high prevalence rate of diabetes, rise in geriatric population, technological advancements in diabetes care devices, and increase in cases of lifestyle-induced diabetes. These devices have been popular among patients as well as healthcare providers, as these are easy to operation and offer a host of benefits. However, there can be adverse effects of some of these devices in few patients, which hampers the market growth. 

North America witnessed the highest sales of self-monitoring blood glucose devices products, owing to increased awareness toward diabetes management and heavy expenditure by the government on improving healthcare. It is followed by Europe and Asia-Pacific. In addition, the manufacturers and distributors of self-monitoring blood glucose devices product have focused on expanding their presence in the emerging economies, which would drive the market growth.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request Sample

Request Customization

Request sample

OR

Purchase Full Report of
Self-Monitoring Blood Glucose Devices Market- Global Opportunity Analysis and Industry Forecast, 2018-2025

  • Online Only
  • $3456
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $3840
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5370
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6450
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $8995
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo